STOCK TITAN

bluebird bio to Present at Cowen Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

bluebird bio (NASDAQ: BLUE) will participate in the Cowen 41st Annual Health Care Conference on March 3, at 2:40 p.m. ET. A live webcast of the presentation can be accessed via the Investors & Media section of their website. The replay will be available for 90 days post-event. bluebird bio focuses on developing gene therapies for severe genetic diseases and cancer, aiming to provide treatment options for life-threatening conditions. The company operates from multiple locations, including Cambridge, MA, and Zug, Switzerland.

Positive
  • None.
Negative
  • None.

bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will participate in the Cowen 41st Annual Health Care Conference, Wednesday, March 3, at 2:40 p.m. ET.

To access the live webcast of bluebird bio’s presentation, please visit the “Events & Presentations” page within the Investors & Media section of the bluebird bio website at http://investor.bluebirdbio.com. A replay of the webcast will be available on the bluebird bio website for 90 days following the event.

About bluebird bio, Inc.

bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., headquarters, we’re developing gene and cell therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully. Beyond our labs, we’re working to positively disrupt the healthcare system to create access, transparency and education so that gene therapy can become available to all those who can benefit.

bluebird bio is a human company powered by human stories. We’re putting our care and expertise to work across a spectrum of disorders: cerebral adrenoleukodystrophy, sickle cell disease, β-thalassemia and multiple myeloma, using gene and cell therapy technologies including gene addition, and (megaTAL-enabled) gene editing.

bluebird bio has additional nests in Seattle, Wash.; Durham, N.C.; and Zug, Switzerland. For more information, visit bluebirdbio.com.

Follow bluebird bio on social media: @bluebirdbio, LinkedIn, Instagram and YouTube.

bluebird bio is a trademark of bluebird bio, Inc.

FAQ

When is bluebird bio's presentation at the Cowen 41st Annual Health Care Conference?

bluebird bio will present on March 3 at 2:40 p.m. ET.

How can I access the live webcast of bluebird bio's presentation?

The live webcast can be accessed on the Investors & Media section of bluebird bio's website.

What is the focus of bluebird bio's therapies?

bluebird bio develops gene therapies for severe genetic diseases and cancer.

Where is bluebird bio headquartered?

The headquarters of bluebird bio is located in Cambridge, Massachusetts.

For how long will the webcast replay be available after the conference?

The replay of the webcast will be available for 90 days following the event.

bluebird bio, Inc.

NASDAQ:BLUE

BLUE Rankings

BLUE Latest News

BLUE Stock Data

80.75M
193.91M
0.63%
43.76%
25.48%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
SOMERVILLE